HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lanjun Zhang Selected Research

Vinorelbine (Navelbine)

12/2022Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non-Small-Cell Lung Cancer.
11/2018Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lanjun Zhang Research Topics

Disease

28Neoplasms (Cancer)
06/2024 - 11/2009
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2023 - 11/2015
10Lung Neoplasms (Lung Cancer)
06/2023 - 02/2014
9Esophageal Squamous Cell Carcinoma
09/2019 - 10/2013
7Neoplasm Metastasis (Metastasis)
06/2024 - 11/2009
5Adenocarcinoma of Lung
06/2023 - 09/2014
5Lymphatic Metastasis
01/2023 - 09/2015
3Hemorrhage
09/2020 - 09/2017
3Carcinogenesis
02/2017 - 11/2009
2Adenocarcinoma
11/2018 - 11/2015
2Esophageal Neoplasms (Esophageal Cancer)
09/2018 - 05/2016
2Inflammation (Inflammations)
01/2018 - 05/2016
2Carcinoma (Carcinomatosis)
05/2016 - 02/2014
1Brain Neoplasms (Brain Tumor)
03/2023
1Genomic Instability
01/2022
1Pneumothorax
09/2020
1Pain (Aches)
09/2020
1Lacerations
12/2019
1Wounds and Injuries (Trauma)
12/2019
1Hepatocellular Carcinoma (Hepatoma)
09/2019
1Pneumonia (Pneumonitis)
04/2019
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2019
1Exanthema (Rash)
11/2018
1Weight Loss (Weight Reduction)
09/2018
1Deglutition Disorders (Dysphagia)
09/2018
1Hypercapnia
09/2017
1Lung Injury
09/2017
1Rare Diseases (Rare Disease)
11/2015
1Sarcoma (Soft Tissue Sarcoma)
09/2014
1Lymphoma (Lymphomas)
09/2014
1Disease Progression
10/2013

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
06/2024 - 01/2019
5ErbB Receptors (EGF Receptor)IBA
03/2023 - 09/2014
4RNA (Ribonucleic Acid)IBA
01/2022 - 02/2017
3AlbuminsIBA
01/2023 - 01/2017
3C-Reactive ProteinIBA
01/2023 - 05/2016
3Tumor Biomarkers (Tumor Markers)IBA
01/2022 - 02/2014
2Vinorelbine (Navelbine)FDA LinkGeneric
12/2022 - 11/2018
2Cisplatin (Platino)FDA LinkGeneric
12/2022 - 11/2018
2Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2022 - 11/2018
2Indicators and Reagents (Reagents)IBA
09/2019 - 05/2016
2Carcinoembryonic AntigenIBA
05/2016 - 02/2014
2Messenger RNA (mRNA)IBA
11/2015 - 02/2014
1EnzymesIBA
06/2024
1Stem Cell FactorIBA
06/2024
1Aldehyde DehydrogenaseIBA
06/2024
1Immune Checkpoint InhibitorsIBA
06/2023
1Epidermal Growth Factor (EGF)IBA
12/2022
1Long Noncoding RNAIBA
01/2022
1RNA-Binding Proteins (RNA-Binding Protein)IBA
03/2021
1DNA (Deoxyribonucleic Acid)IBA
06/2020
1TitaniumIBA
02/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Hemostatics (Antihemorrhagics)IBA
12/2019
1Formaldehyde (Formol)FDA Link
11/2019
1ParaffinIBA
11/2019
1alpha-L-Fucosidase (Fucosidase)IBA
09/2019
1ElementsIBA
11/2018
1Tyrosine Kinase InhibitorsIBA
01/2018
1Carbon DioxideIBA
09/2017
1urinastatin (MR 20)IBA
09/2017
1Budesonide (Pulmicort)FDA LinkGeneric
09/2017
1sivelestatIBA
09/2017
1Oxygen (Dioxygen)IBA
09/2017
1Adenosine (Adenocard)FDA LinkGeneric
02/2017
1immune RNA (I-RNA)IBA
02/2017
1Fibrinogen (Factor I)FDA Link
01/2017
1squamous cell carcinoma-related antigenIBA
05/2016
1Serum AlbuminIBA
05/2016
1Gonadal Steroid Hormones (Sex Hormones)IBA
05/2016
1Hemoglobins (Hemoglobin)IBA
01/2016
1Telomerase (Telomerase Reverse Transcriptase)IBA
11/2015
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
09/2014
1Phosphotransferases (Kinase)IBA
09/2014
1Phosphopyruvate Hydratase (Enolase)IBA
02/2014
1Keratins (Keratin)IBA
02/2014
1Interleukin-17 (Interleukin 17)IBA
10/2013
1CytokinesIBA
10/2013
1Oncogene Proteins (Oncogene Protein)IBA
11/2009
1NF-kappa B (NF-kB)IBA
11/2009

Therapy/Procedure

11Esophagectomy
05/2021 - 11/2012
7Immunotherapy
06/2023 - 01/2019
6Therapeutics
01/2023 - 01/2018
4Lymph Node Excision (Lymph Node Dissection)
06/2023 - 03/2018
3Drug Therapy (Chemotherapy)
12/2022 - 09/2018
2Ligation
01/2023 - 12/2019
2Adjuvant Chemotherapy
12/2022 - 11/2018
2Thoracotomy
12/2019 - 09/2017
2Length of Stay
04/2019 - 09/2017
1Pneumonectomy (Lung Volume Reduction)
01/2023
1Punctures
09/2020
1Electrocoagulation (Electrocautery)
12/2019
1Aftercare (After-Treatment)
01/2019
1Minimally Invasive Surgical Procedures
10/2018
1Neoadjuvant Therapy
09/2018
1Operative Surgical Procedures
03/2018
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
09/2017
1Artificial Respiration (Mechanical Ventilation)
09/2017
1One-Lung Ventilation
09/2017
1Chest Tubes (Chest Tube)
09/2017